Condition: Breast Cancer · Reconstructive Surgery · Breast Reconstruction · Sponsor: Maastricht University Medical Center
A multicentre prospective cohort study will monitor the efficacy and safety of Autologous Fat Transfer (AFT) with pre-expansion. AFT will be evaluated in terms of quality of life, aesthetic result, complications, oncological safety and cost-effectiveness. It follows the BREAST trial, the randomised controlled trial comparing AFT with implant-based reconstruction. In this study, patients all receive AFT.
This description comes directly from the study's public registry record.
Jamilla Wederfoort, MD, MSc · 0031-(0)43 387 2308 · sander.schop@mumc.nl
Always discuss trial participation with your own doctor first.
| Maastricht University Medical Center+ | Maastricht, Limburg, Netherlands | Enrolling By Invitation |
| Viecuri Venlo | Venlo, Limburg, Netherlands | Recruiting |
| Amsterdam University Medical Center (VUMC) | Amsterdam, Netherlands | Enrolling By Invitation |
| Rijnstate | Arnhem, Netherlands | Enrolling By Invitation |
| Alexander Monro, Bilthoven | Bilthoven, Netherlands | Enrolling By Invitation |
| Amphia | Breda, Netherlands | Enrolling By Invitation |
| Ziekenhuis groep Twente (ZGT) | Hengelo, Netherlands | Recruiting |
| Medical Center Leeuwarden | Leeuwarden, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04261829